MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Pediatrics_Fetal, Neonatal, Infant, Children, Adolescents (Teens) & Youth
2029: NICHD_Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
Attachments
PAR-25-362: Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
Parents
*Funding: HIV/AIDS & STD (Sexually Transmitted Disease)
*Funding: NIH_NICHD
*Funding: Pediatrics_Fetal, Neonatal, Infant, Children, Adolescents (Teens) & Youth
Funding: Federal R&D (Research and Development)_NOFO_PAR, PA, PAS, RFA, RFP, Grant, BAA, Cooperative Agreements (CAs)
Children
2023: NICHD_Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)
The purpose of this NOFO is to further elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART). This initiative aims to understand intricate mechanisms of immune cells at the maternal-fetal interface, T and B cell development and maturation in offspring, and local immune responses and the role of systemic immunity.